Furthermore, the loss of GAP-43 could dysregulate cytokine expression, leading to chronic low-grade inflammation, which is known to promote cardiac hypertrophy like NF-κB or JAK/STAT signaling [51,52]. The gene discussed is SOAT1; the disease is cardiac hypertrophy.